These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15160713)

  • 1. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 May; 69(101):29785-834. PubMed ID: 15160713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(226):68611-88. PubMed ID: 15562555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS
    Fed Regist; 2005 May; 70(100):29949-52. PubMed ID: 15915582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2001 Jan; 66(13):5447-69. PubMed ID: 11503777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General requirements for blood, blood components, and blood derivatives; donor notification. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jun; 66(112):31165-77. PubMed ID: 11725787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule.
    Fed Regist; 1998 May; 63(93):26744-55. PubMed ID: 10179343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cells, tissues, and cellular and tissue-based products; establishment registration and listing. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jan; 69(17):3823-6. PubMed ID: 14968801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current regulatory issues in cell and tissue therapy.
    Burger SR
    Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for testing human blood donors for evidence of infection due to communicable disease agents. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Jun; 66(112):31146-65. PubMed ID: 11725786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(216):66621-35. PubMed ID: 11503696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisions to Exceptions Applicable to Certain Human Cells, Tissues, and Cellular and Tissue-Based Products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Jun; 81(120):40512-8. PubMed ID: 27373010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amendment to the current good manufacturing practice regulations for finished pharmaceuticals. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Dec; 72(232):68064-70. PubMed ID: 18064770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beverages: bottled water. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Mar; 68(41):9873-82. PubMed ID: 12625359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current good manufacturing practice regulation and investigational new drugs. Direct final rule.
    Food and Drug Administration. HHS
    Fed Regist; 2006 Jan; 71(10):2458-62. PubMed ID: 16479693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beverages: bottled water. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Jun; 70(110):33694-701. PubMed ID: 15945150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of communicable diseases; apprehension and detention of persons with specific diseases; transfer of regulations. Food and Drug Administration and Centers for Disease Control and Prevention, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(159):49906-9. PubMed ID: 11067729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief report: investigation into recalled human tissue for transplantation--United States, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 May; 55(20):564-6. PubMed ID: 16723969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tissue intended for transplantation--FDA. Interim rule; opportunity for public comment.
    Fed Regist; 1993 Dec; 58(238):65514-21. PubMed ID: 10131341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drug and antibiotic regulations--FDA. Proposed rule.
    Fed Regist; 1982 Oct; 47(202):46622-66. PubMed ID: 10262075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA improves safety of human cells and tissues.
    FDA Consum; 2005; 39(1):5. PubMed ID: 15803584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.